Ástralía - enska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin potassium, quantity: 280 mg (equivalent: phenoxymethylpenicillin, qty 250 mg) - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; titanium dioxide; vanillin; quinoline yellow; purified talc; xanthan gum; polyvinyl alcohol; lecithin; hypromellose; macrogol 6000 - treatment of mild to moderately severe infections caused by penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham?s chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note: oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth..

Bandaríkin - enska - NLM (National Library of Medicine)

proficient rx lp - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution and other antibacterial drugs, penicillin v potassium tablets, and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericardit

Bandaríkin - enska - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution and other antibacterial drugs, penicillin v potassium tablets, and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericardit

Bandaríkin - enska - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution and other antibacterial drugs, penicillin v potassium tablets, and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericardit

Bandaríkin - enska - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution and other antibacterial drugs, penicillin v potassium tablets, and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericardit

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

viatris limited - phenoxymethylpenicillin potassium 279mg equivalent to phenoxymethylpenicillin 250 mg (actual formula based on 100% potency); phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg; phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg; phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg - capsule - 250 mg - active: phenoxymethylpenicillin potassium 279mg equivalent to phenoxymethylpenicillin 250 mg (actual formula based on 100% potency) excipient: brilliant blue fcf erythrosine gelatin magnesium stearate opacode white s-1-7085 sunset yellow fcf titanium dioxide active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: capsugel orange op.c027 magnesium stearate active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: capsugel orange op.c027 magnesium stearate active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: gelatin capsule - maroon - mi01429 gelatin capsule - maroon - mi01430 magnesium stearate - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - phenoxymethylpenicillin potassium, quantity: 56.568 mg/ml (equivalent: phenoxymethylpenicillin, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: sucrose; sodium benzoate; saccharin sodium; flavour; colour - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms such as penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea. for the prevention of bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - phenoxymethylpenicillin potassium, quantity: 28.284 mg/ml (equivalent: phenoxymethylpenicillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: sucrose; sodium benzoate; saccharin sodium; colour; flavour - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms such as penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea. for the prevention of bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.

Malta - enska - Malta Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - phenoxymethylpenicillin - tablet - phenoxymethylpenicillin 250 mg - antibacterials for systemic use

Írland - enska - HPRA (Health Products Regulatory Authority)

morningside healthcare limited - phenoxymethylpenicillin - film coated tablet - 250 milligram - phenoxymethylpenicillin